M&A Deal Summary

Malin Acquires Altan Pharma

On June 11, 2015, Malin acquired life science company Altan Pharma for 35M USD

Acquisition Highlights
  • This is Malin’s 2nd transaction in the Life Science sector.
  • This is Malin’s largest (disclosed) transaction.
  • This is Malin’s 1st transaction in Ireland.
Investment Fate
  • Altan Pharma was divested to a consortium of strategic buyers in 2021.

M&A Deal Summary
Date 2015-06-11
Target Altan Pharma
Sector Life Science
Buyer(s) Malin
Deal Type Add-on Acquisition
Deal Value 35M USD

Target

Altan Pharma

Dublin, Ireland
Altan Pharma is a pharmaceutical company that develops, manufactures, and markets injectable medications for the hospital and other provider segments. Altan Pharma was founded in 2015 and is based in Dublin, Ireland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Malin

Dublin, Ireland
Category Company
Founded 2014
Sector Life Science
Employees255
Revenue 41M EUR (2020)
DESCRIPTION

Malin is a globally operating life sciences company. Malin was founded in 2014 and is based in Dublin, Ireland.

DEAL STATS #
Overall 2 of 8
Sector (Life Science) 2 of 6
Type (Add-on Acquisition) 1 of 3
Country (Ireland) 1 of 3
Year (2015) 1 of 4
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-05-02 Melinta Therapeutics

New Haven, Connecticut, United States

Melinta Therapeutics is a molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-01 3D4Medical

Dublin, Ireland

3D4Medical Ltd. specializes in the development of medical, educational and health and fitness apps for healthcare professionals as well as student and patient education.

Buy -
Mergr

Product

Company

Legal